Filter32m
FDA’s Authorization of Zyn Nicotine Pouches a Step in the Right Direction
The groundbreaking decision is a win for harm reduction, though it also highlights absurd contradictions in the FDA's overall approach.
Analysts Fail to Light Up Philip Morris Stock Despite Price Target Hikes
Tobacco group Philip Morris (PM) has fired up some key analysts after posting strong Q4 earnings. Four-star TipRanks-rated analyst Matthew ...